Skip to main content

Advancing Innovative Stem Cell-based Therapy for Diabetes in Europe

Project description

Islets could change the medical landscape for diabetes patients

Field of science

  • /medical and health sciences/clinical medicine/endocrinology/diabetes
  • /medical and health sciences/medical biotechnology/cells technologies/stem cells
  • /medical and health sciences/basic medicine/pharmacology and pharmacy/pharmaceutical drug

Call for proposal

H2020-SC1-2019-Single-Stage-RTD
See other projects for this call

Funding Scheme

RIA - Research and Innovation action

Coordinator

KOBENHAVNS UNIVERSITET
Address
Norregade 10
1165 Kobenhavn
Denmark
Activity type
Higher or Secondary Education Establishments
EU contribution
€ 3 137 448,51

Participants (6)

HELMHOLTZ ZENTRUM MUENCHEN DEUTSCHES FORSCHUNGSZENTRUM FUER GESUNDHEIT UND UMWELT GMBH
Germany
EU contribution
€ 1 640 425
Address
Ingolstadter Landstrasse 1
85764 Neuherberg
Activity type
Research Organisations
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE
France
EU contribution
€ 848 750
Address
Rue De Tolbiac 101
75654 Paris
Activity type
Research Organisations
ACADEMISCH ZIEKENHUIS LEIDEN
Netherlands
EU contribution
€ 851 750
Address
Albinusdreef 2
2333 ZA Leiden
Activity type
Higher or Secondary Education Establishments
KLINIKUM RECHTS DER ISAR DER TECHNISCHEN UNIVERSITAT MUNCHEN
Germany
EU contribution
€ 558 500
Address
Ismaninger Strasse 22
81675 Muenchen
Activity type
Higher or Secondary Education Establishments
LIPOTYPE
Germany
EU contribution
€ 758 750,24
Address
Tatzberg 47
01307 Dresden
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
FEDERATION INTERNATIONALE DU DIABETE REGION EUROPE AISBL
Belgium
EU contribution
€ 204 375
Address
Chaussee De La Hulpe 166 Bloc C
1170 Bruxelles
Activity type
Other